Prevalence of HPV in male-to-female transgender neovagina in KCMH

Not Applicable

• Conditions: HPV infection; transgender; neovagina; anus; HPV DNA; cytology

• Registration Number: TCTR20181104005
• Lead Sponsor: Rachadapiseksompotch Fund

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-11-04
• Study Completion: 2019-01-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: Male
• Target Recruitment: 62

Inclusion Criteria

female-to-male transgender with neovagina

Exclusion Criteria

- marked stenosis of neovagina

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HPV DNA PCR from neovagina immediate positive/negative

Secondary Outcome Measures

Name	Time	Method
HPV DNA PCR from anus immediate positive/negative,neovaginal cytology immediate cytology